Oxaprozin
is a nonsteroidal anti-inflammatory biologic (NSAID) with analgesic and
antipyretic properties. Oxaprozin is acclimated to amusement rheumatoid
arthritis, osteoarthritis, dysmenorrhea, and to allay abstinent pain.
Oxaprozin
is accepted to be excreted in animal milk based on its physical-chemical
properties; however, the bulk of oxaprozin excreted in breast milk has not been
evaluated. Approximately 95% of oxaprozin is metabolized by the liver.
Approximately 5% of the oxaprozin dosage is excreted banausic in the urine.
Sixty-five percent (65%) of the dosage is excreted in the urine and 35% in the
carrion as metabolite. Biliary elimination of banausic oxaprozin is a accessory
pathway. Several oxaprozin metabolites accept been articular in animal urine or
feces.
No comments:
Post a Comment